Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
Journal of Clinical Oncology.
Times cited: 51
Development of investigational radiation modifiers.
Journal of the National Cancer Institute.
Times cited: 26